Drug
estradiol, 10 mcg
estradiol, 10 mcg is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_1
1
25%
Ph phase_3
3
75%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 33 (75.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis
NCT00431132
completedphase_3
Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis
NCT00465192
completedphase_3
Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
NCT00108849
completedphase_1
Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
NCT01486979
Clinical Trials (4)
Showing 4 of 4 trials
NCT00431132Phase 3
Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis
NCT00465192Phase 3
Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis
NCT00108849Phase 3
Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
NCT01486979Phase 1
Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4